Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation. [electronic resource]
Producer: 20071130Description: 2808-14 p. digitalISSN:- 1097-0215
- Adenocarcinoma -- drug therapy
- Antimetabolites, Antineoplastic -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Benzamides
- Blotting, Western
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Colonic Neoplasms -- drug therapy
- Enzyme Activation -- drug effects
- Enzyme Precursors -- drug effects
- Fluorouracil -- pharmacology
- Gelatinases -- drug effects
- Gene Expression Regulation, Enzymologic -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Imatinib Mesylate
- Matrix Metalloproteinase 14 -- drug effects
- Metalloendopeptidases -- drug effects
- Piperazines -- pharmacology
- Proto-Oncogene Proteins c-kit -- metabolism
- Pyrimidines -- pharmacology
- Reverse Transcriptase Polymerase Chain Reaction
- Tissue Inhibitor of Metalloproteinases -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.